The Journal of Organic Chemistry
Article
(ESI/Q-TOF): m/z calcd for C23H17N2O2S (M + H)+ 385.1011,
found 385.1013.
NMR (400 MHz, CDCl3): δ 7.53−7.43 (m, 3H), 7.25−7.22 (m, 2H),
6.57−6.51 (m, 2H), 6.12−6.08 (m, 1H), 2.98 (s, 3H); 13C{1H} NMR
(101 MHz, CDCl3): δ 176.3, 164.5, 157.4, 156.2, 144.3, 133.0, 133.0,
131.4, 129.3, 128.5, 127.7, 122.9, 119.3, 119.2, 105.9, 69.9, 26.6; 19F
NMR (377 MHz, CDCl3): δ −119.75; IR (KBr): νmax = 3050, 2164,
1714, 1380, 1173, 760 cm−1; HRMS (ESI/Q-TOF): m/z calcd for
C17H12FN2O2S (M + H)+ 327.0604, found 327.0611.
1-(2-Iodobenzyl)-4-phenyl-3-thiocyanato-1-azaspiro[4.5]deca-
3,6,9-triene-2,8-dione (2p). Following the general procedure, N-(2-
iodobenzyl)-N-(4-methoxyphenyl)-3-phenylpropiolamide 1p (144
mg, 0.3 mmol), AgSCN (101 mg, 0.6 mmol), and CAN (489 mg,
0.9 mmol) were reacted in DMSO (3 mL). After the workup, column
chromatography purification gave 2p as a brown solid (131 mg, 86%
1-(2-Iodobenzyl)-7-methyl-4-phenyl-3-thiocyanato-1-azaspiro-
[4.5]deca-3,6,9-triene-2,8-dione (2u). Following the general proce-
dure, N-(2-iodobenzyl)-N-(4-methoxy-3-methylphenyl)-3-phenylpro-
piolamide 1u (128 mg, 0.3 mmol), AgSCN (102 mg, 0.6 mmol), and
CAN (494 mg, 0.9 mmol) were reacted in DMSO (3 mL). After the
workup, column chromatography purification gave 2u as a white solid
(141 mg, 89% yield). Mp: 143−145 °C; Rf = 0.3 (hexane:ethyl acetate
1
yield). Mp: 113−115 °C; Rf = 0.4 (hexane:ethyl acetate = 7:3); H
NMR (400 MHz, CDCl3) δ 7.77 (d, J = 7.8 Hz, 1H), 7.47−7.35 (m,
4H), 7.30 (d, J = 7.4 Hz, 1H), 7.18 (d, J = 7.3 Hz, 2H), 6.97 (t, J = 7.4
Hz, 1H), 6.29 (q, J = 10.2 Hz, 4H), 4.77 (s, 2H); 13C{1H} NMR (101
MHz, CDCl3) δ 183.5, 165.2, 157.7, 142.4, 139.7, 138.9, 133.5, 131.1,
130.3, 129.9, 129.0, 128.8, 128.6, 127.8, 122.2, 106.2, 99.7, 68.8, 49.7;
IR (KBr): νmax = 3055, 2163, 1709, 1389, 756 cm−1; HRMS (ESI/Q-
TOF): m/z calcd for C23H16N2O2SI (M + H)+ 510.9977, found
510.9988.
1
= 7:3); H NMR (500 MHz, CDCl3): δ 7.77 (dd, J = 8.0, 1.1 Hz,
1H), 7.45−7.41 (m, 2H), 7.39−7.35 (m, 2H), 7.31− 7.29 (m, 1H),
7.17−7.14 (m, 2H), 6.97−6.93 (m, 1H), 6.30−6.25 (m, 2H), 5.98−
5.96 (m, 1H), 4.86 (d, J = 15.3 Hz, 1H), 4.68 (d, J = 15.3 Hz, 1H),
1.72 (d, J = 1.4 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ 184.4,
165.2, 158.5, 142.2, 140.9, 139.6, 139.3, 137.3, 133.4, 131, 130.3,
129.9, 128.9, 128.9, 128.8, 127.7, 121.6, 106.4, 99.8, 69.2, 49.5, 16.0;
IR (KBr): νmax = 2923, 2167, 1707, 1643, 1386, 757 cm−1; HRMS
(ESI/Q-TOF): m/z calcd for C24H18N2O2SI (M + H)+ 525.0134,
found 525.0136.
7-Methyl-4-phenyl-3-thiocyanato-1-(2-(trifluoromethyl)benzyl)-
1-azaspiro[4.5]deca-3,6,9-triene-2,8-dione (2q). Following the
general procedure, N-(4-methoxy-3-methylphenyl)-3-phenyl-N-(2-
(trifluoromethyl)benzyl)propiolamide 1q (127 mg, 0.3 mmol),
AgSCN (102 mg, 0.6 mmol), and CAN (494 mg, 0.9 mmol) were
reacted in DMSO (3 mL). After the workup, column chromatography
purification gave 2q as a yellow solid (114 mg, 81% yield). Mp: 139−
1
141 °C; Rf = 0.5 (hexane:ethyl acetate = 7:3); H NMR (400 MHz,
1-Phenyl-2-thiocyanato-6,7-dihydro-3H-pyrrolo[2,1-j]quinoline-
3,9(5H)-dione (4). Following the general procedure, 1-(6-methoxy-
3,4-dihydroquinolin-1(2H)-yl)-3-phenylprop-2-yn-1-one 3 (88 mg,
0.3 mmol), AgSCN (101 mg, 0.6 mmol), and CAN (489 mg, 0.9
mmol) were reacted in DMSO (3 mL). After the workup, column
chromatography purification gave 4 as a brown solid (80 mg, 80%
CDCl3): δ 7.54 (t, J = 8.5 Hz, 2H), 7.48−7.36 (m, 5H), 7.19−7.13
(m, 2H), 6.39−6.33 (m, 2H), 6.01 (dd, J = 2.4, 1.4 Hz, 1H), 4.78 (d,
J = 15.1 Hz, 1H), 4.44 (d, J = 15.1 Hz, 1H), 1.74 (d, J = 1.5 Hz, 3H);
13C{1H} NMR (101 MHz, CDCl3): δ 184.0, 165.3, 158.3, 142.6,
140.7, 138.0, 137.8, 133.4, 132.6, 131.3, 131.1, 130.9, 129.4, 129.0,
128.7, 127.7, 125.7, 125.0, 121.7, 106.3, 69.2, 44.9, 15.6; 19F NMR
(377 MHz, CDCl3) δ −62.99; IR (KBr): νmax = 3063, 2164, 1700,
1
yield). Mp: 147−149 °C; Rf = 0.3 (hexane:ethyl acetate = 6:4); H
NMR (500 MHz, CDCl3): δ 7.47−7.43 (m, 1H), 7.41−7.37 (m, 2H),
7.08−7.05 (m, 2H), 6.54−6.52 (m, 1H), 6.40 (t, J = 1.5 Hz 1H),
6.28−6.24 (m, 1H), 4.28−4.22 (m, 1H), 2.90−2.82 (m, 1H), 2.59−
2.50 (m, 2H), 2.08−2.00 (m, 1H), 1.94−1.87 (m, 1H); 13C{1H}
NMR (101 MHz, CDCl3): δ 183.9, 168.7, 158.6, 156.4, 144.5, 132.9,
131.0, 129.9, 128.9, 128.3, 127.9, 122.9, 106.2, 72.3, 37.2, 26.8, 26.2;
IR (KBr): νmax 2951, 2163, 1709, 1667, 1377, 753 cm−1; HRMS
(ESI/Q-TOF): m/z calcd for C19H15N2O2S (M + H)+ 335.0854,
found 335.0857.
1670, 737 cm−1
; HRMS (ESI/Q-TOF): m/z calcd for
C25H18F3N2O2S (M + H)+ 467.1041, found 467.1040.
1,6-Dimethyl-4-phenyl-3-thiocyanato-1-azaspiro[4.5]deca-
3,6,9-triene-2,8-dione (2r). Following the general procedure, N-(4-
methoxy-2-methylphenyl)-N-methyl-3-phenylpropiolamide 1r (84
mg, 0.3 mmol), AgSCN (102 mg, 0.6 mmol), and CAN (492 mg,
0.9 mmol) were reacted in DMSO (3 mL). After the workup, column
chromatography purification gave 2r as a white solid (85 mg, 88%
1
yield). Mp: 163-165 °C; Rf = 0.3 (hexane:ethyl acetate = 7:3); H
4-Phenyl-3-thiocyanato-1-oxaspiro[4.5]deca-3,6,9-triene-2,8-
dione (6a). Following the general procedure, 4-methoxyphenyl 3-
phenylpropiolate 5a (76 mg, 0.3 mmol), AgSCN (102 mg, 0.6 mmol),
and CAN (493 mg, 0.9 mmol) were reacted in DMSO (3 mL). After
the workup, column chromatography purification gave 6a as a brown
NMR (500 MHz, CDCl3): δ 7.50−7.46 (m, 1H), 7.45−7.41 (m, 2H),
7.28−7.27 (m, 1H), 7.26−7.25 (m, 1H), 6.54 (dd, J = 9.9, 1.7 Hz,
1H), 6.46 (d, J = 9.9 Hz, 1H), 6.40−6.38 (m, 1H), 2.86 (s, 3H), 1.76
(d, J = 1.4 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ 184.1,
165.5, 157.4, 151.5, 143.2, 133.5, 132.6, 131.4, 129.3, 128.7, 127.6,
122.4, 106.3, 70.5, 26.2, 17.7; IR (KBr): νmax = 3016, 2163, 1709,
1389, 757 cm−1; HRMS (ESI/Q-TOF): m/z calcd for C18H15N2O2S
(M + H)+ 323.0854, found 323.0858.
1
liquid (73 mg, 82% yield), Rf = 0.4 (hexane:ethyl acetate = 7:3); H
NMR (400 MHz, CDCl3): δ 7.57−7.52 (m, 1H), 7.51-7.45 (m, 2H),
7.36−7.31 (m, 2H), 6.71−6.65 (m, 2H), 6.50−6.43 (m, 2H);
13C{1H} NMR (101 MHz, CDCl3): δ 183.1, 165.9, 165.7, 140.6,
1,7-Dimethyl-4-phenyl-3-thiocyanato-1-azaspiro[4.5]deca-
3,6,9-triene-2,8-dione (2s). Following the general procedure, N-(4-
methoxy-3-methylphenyl)-N-methyl-3-phenylpropiolamide 1s (84
mg, 0.3 mmol), AgSCN (112 mg, 0.6 mmol), and CAN (492 mg,
0.9 mmol) were reacted in DMSO (3 mL). After the workup, column
chromatography purification gave 2s as a white solid (86 mg, 89%
139.7, 132.7, 132.3, 129.5, 127.5, 116.4, 105.2, 83.1; IR (neat): νmax =
3058, 2924, 2105, 1772, 1672, 1214, 746 cm−1; HRMS (ESI/Q-
TOF): m/z calcd for C16H10NO3S (M + H)+ 296.0381, found
296.0383.
4-(4-Chlorophenyl)-3-thiocyanato-1-oxaspiro[4.5]deca-3,6,9-tri-
ene-2,8-dione (6b). Following the general procedure, 4-Methox-
yphenyl 3-(4-chlorophenyl)propiolate 5b (86 mg, 0.3 mmol), AgSCN
(102 mg, 0.6 mmol), and CAN (492 mg, 0.9 mmol) were reacted in
DMSO (3 mL). After the workup, column chromatography
purification gave 6b as a white solid (77 mg, 78% yield). Mp: 137−
1
yield). Mp: 129−131 °C; Rf = 0.3 (hexane:ethyl acetate = 7:3); H
NMR (500 MHz, CDCl3): δ 7.49−7.44 (m, 1H), 7.44−7.39 (m, 2H),
7.24−7.21 (m, 2H), 6.51−6.45 (m, 2H), 6.28 (dd, J = 2.7, 1.4 Hz,
1H), 2.93 (s, 3H), 1.95 (d, J = 1.4 Hz, 3H); 13C{1H} NMR (101
MHz, CDCl3): δ 184.2, 165, 157.7, 142.9, 141.5, 137.7, 133.7, 131.0,
129.0 (2C), 127.8, 121.9, 106.5, 68.9, 26.5, 16; IR (KBr): νmax = 2923,
2164, 1706, 1642, 1371, 750 cm−1; HRMS (ESI/Q-TOF): m/z calcd
for C18H15N2O2S (M + H)+ 323.0854, found 323.0858.
1
139 °C; Rf = 0.4 (hexane:ethyl acetate = 7:3); H NMR (400 MHz,
CDCl3) δ 7.46 (d, J = 8.5 Hz, 2H), 7.30 (d, J = 8.5 Hz, 2H), 6.66 (d, J
= 10.1 Hz, 2H), 6.48 (d, J = 10.0 Hz, 2H); 13C{1H} NMR (101 MHz,
CDCl3): δ 182.9, 165.7, 164.2, 140.4, 138.9, 132.9, 129.9, 128.9,
125.7, 116.9, 104.9, 83.0; IR (KBr): νmax = 3058, 2166, 1766, 1674,
7-Fluoro-1-methyl-4-phenyl-3-thiocyanato-1-azaspiro[4.5]deca-
3,6,9-triene-2,8-dione (2t). Following the general procedure, N-(3-
fluoro-4-methoxyphenyl)-N-methyl-3-phenylpropiolamide 1t (85 mg,
0.3 mmol), AgSCN (101 mg, 0.6 mmol), and CAN (491 mg, 0.9
mmol) were reacted in DMSO (3 mL). After the workup, column
chromatography purification gave 2t as a yellow solid (90 mg, 92%
1216, 759 cm−1
; HRMS (ESI/Q-TOF): m/z calcd for
C16H12ClN2O3S+ (M + NH4)+: 347.0257, Found: 347.0254.
4-(4-Acetylphenyl)-3-thiocyanato-1-oxaspiro[4.5]deca-3,6,9-tri-
ene-2,8-dione (6c). Following the general procedure, 4-methox-
yphenyl 3-(4-acetylphenyl)propiolate 5c (89 mg, 0.3 mmol), AgSCN
(102 mg, 0.6 mmol), and CAN (494 mg, 0.9 mmol) were reacted in
1
yield). Mp 125−127 °C; Rf = 0.3 (hexane:ethyl acetate = 7:3); H
G
J. Org. Chem. XXXX, XXX, XXX−XXX